Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionsecondary active transmembrane transporter activity

SLC26A7 SLC5A9

1.29e-0329642GO:0015291
GeneOntologyMolecularFunctionactive monoatomic ion transmembrane transporter activity

SLC26A7 SLC5A9

1.33e-0330142GO:0022853
GeneOntologyMolecularFunctionactive transmembrane transporter activity

SLC26A7 SLC5A9

3.31e-0347742GO:0022804
GeneOntologyMolecularFunctioninorganic molecular entity transmembrane transporter activity

SLC26A7 SLC5A9

8.21e-0375842GO:0015318
GeneOntologyMolecularFunctionmonoatomic ion transmembrane transporter activity

SLC26A7 SLC5A9

8.96e-0379342GO:0015075
GeneOntologyMolecularFunctiontransmembrane transporter activity

SLC26A7 SLC5A9

1.93e-02118042GO:0022857
GeneOntologyMolecularFunctiontransporter activity

SLC26A7 SLC5A9

2.29e-02128942GO:0005215
GeneOntologyBiologicalProcesssnRNA processing

INTS6 FTO

1.14e-052942GO:0016180
GeneOntologyBiologicalProcesssnRNA metabolic process

INTS6 FTO

4.81e-055942GO:0016073
GeneOntologyBiologicalProcessregulation of hormone levels

SLC26A7 FTO

6.30e-0368442GO:0010817
MousePhenoabnormal urine homeostasis

SLC26A7 FTO

3.25e-0346632MP:0009643
MousePhenodecreased circulating hormone level

SLC26A7 FTO

4.53e-0355132MP:0014457
MousePhenoincreased circulating hormone level

SLC26A7 FTO

4.98e-0357832MP:0014456
MousePhenodecreased hormone level

SLC26A7 FTO

5.99e-0363532MP:0014455
MousePhenoincreased hormone level

SLC26A7 FTO

6.11e-0364132MP:0014454
MousePhenoabnormal renal/urinary system physiology

SLC26A7 FTO

7.16e-0369532MP:0005502
PathwayREACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT

SLC26A7 SLC5A9

1.67e-0323842MM15076
PathwayREACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT

SLC26A7 SLC5A9

1.82e-0324942M5988
PathwayREACTOME_TRANSPORT_OF_SMALL_MOLECULES

SLC26A7 SLC5A9

1.31e-0268142MM14985
PathwayREACTOME_TRANSPORT_OF_SMALL_MOLECULES

SLC26A7 SLC5A9

1.52e-0273642M27287
InteractionDDX24 interactions

INTS6 FTO

5.04e-0359642int:DDX24
InteractionNXF1 interactions

INTS6 FTO

2.44e-02134542int:NXF1
GeneFamilySolute carriers

SLC26A7 SLC5A9

2.77e-0339542752
CoexpressionGRYDER_PAX3FOXO1_ENHANCERS_IN_TADS

INTS6 FTO

8.43e-03100942M157
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

INTS6 SLC5A9

8.37e-0516942cd16e8462ee09877be962fbd9a3badcb825820b0
Drugbicarbonate

INTS6 SLC26A7 FTO

1.14e-0532543CID000000767
Drugglibenclamide

SLC26A7 FTO

1.65e-0338242CID000003488
DrugVancomycin

SLC26A7 SLC5A9

9.00e-0390642ctd:D014640
Drugethylnylestradiol

INTS6 FTO

1.68e-02125142CID000003285
Diseasebody fat distribution

SLC26A7 FTO

2.77e-0420242EFO_0004341
Diseaseuric acid measurement

SLC5A9 FTO

2.49e-0361042EFO_0004761
Diseaseurate measurement

SLC5A9 FTO

5.29e-0389542EFO_0004531

Protein segments in the cluster

PeptideGeneStartEntry
LKTMPPYYLGPLKKA

INTS6

416

Q9UL03
PYYLGPLKKAVRMMG

INTS6

421

Q9UL03
KMPYLKEEPYFGMGK

FTO

211

Q9C0B1
GGYLKILPMFFIVMP

SLC5A9

321

Q2M3M2
KYLLGMKMPYISGPL

SLC26A7

196

Q8TE54